» Articles » PMID: 18446711

Oxidative Stress, Inflammation and Cardiovascular Disease in Chronic Renal Failure

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2008 May 1
PMID 18446711
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional risk factors such as hypertension, diabetes, dyslipidemia, obesity and metabolic syndrome, as well as additional nontraditional risk factors, can damage the kidney directly and by promoting intrarenal atherogenesis. Evidence indicates that increased oxidative stress and inflammation may mediate most of the effects of risk factors on the kidney. Clinical studies have demonstrated a relationship between oxidative stress and inflammatory biomarkers, and a few studies indicate an inverse correlation of oxidative stress biomarkers with estimated glomerular filtration rate (eGFR). Further, surrogate indexes of atherosclerosis such as intima-media thickness and aortic pulse wave velocity have been demonstrated to be related to plasma concentrations of markers of endothelial activation, inflammation and fibrosis in patients with different stages of chronic kidney disease (CKD). Moreover, plasma concentrations of high-sensitivity C-reactive protein have been shown to be increased and related to left ventricular mass in CKD individuals having left ventricular hypertrophy. In contrast, in these patients, decreases in fetuin-A plasma levels have been reported. Considering the complex background of the pathophysiological changes characterizing CKD patients, we can consider cardiovascular disease a multifactorial complication of CKD.

Citing Articles

Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors.

Carullo N, Sorbo D, Faga T, Pugliese S, Zicarelli M, Costa D Int J Mol Sci. 2024; 25(23).

PMID: 39684548 PMC: 11641783. DOI: 10.3390/ijms252312838.


Association of the oxidative balance score and chronic kidney disease: insights from the national health and nutrition examination survey 2009-2018.

Chen X, Wu Z, Hou X, Yu W, Gao C, Gou S Front Nutr. 2024; 11:1429191.

PMID: 39399530 PMC: 11468420. DOI: 10.3389/fnut.2024.1429191.


Ceruloplasmin, Catalase and Creatinine Concentrations Are Independently Associated with All-Cause Mortality in Patients with Advanced Heart Failure.

Smyla-Gruca W, Szczurek-Wasilewicz W, Skrzypek M, Karmanski A, Romuk E, Jurkiewicz M Biomedicines. 2024; 12(3).

PMID: 38540275 PMC: 10968199. DOI: 10.3390/biomedicines12030662.


Correlation of renal function indicators and vascular damage in T2DM patients with normal renal function.

Zhang Y, Gui J, Chen B, Wan Q Front Endocrinol (Lausanne). 2024; 14:1292397.

PMID: 38164493 PMC: 10758123. DOI: 10.3389/fendo.2023.1292397.


Nifuroxazide attenuates indomethacin-induced renal injury by upregulating Nrf2/HO-1 and cytoglobin and suppressing NADPH-oxidase, NF-κB, and JAK-1/STAT3 signals.

Hassanein E, Abdel-Reheim M, Althagafy H, Hemeda M, Gad R, Abdel-Sattar A Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3985-3994.

PMID: 37994949 DOI: 10.1007/s00210-023-02851-5.